HeXem Bio Inc.
- Biotech or pharma, therapeutic R&D
- Other R&D services
HeXem Bio is pioneering the first blood stem cell rejuvenation therapy, built on a breakthrough platform that mimics the embryonic niche using the world’s first synthetic human yolk sac. This proprietary, IP-protected technology enables the rejuvenation and expansion of hematopoietic stem cells (HSCs) and their derivatives, unlocking curative therapies for conditions previously considered untreatable—including bone marrow failure, Alzheimer’s, infertility, liver, and skin diseases.
We are looking for co-development / research / commercialization partnerships and investment opportunities.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}